Type 1 diabetes trials in China

In China 40 Also abroad 537

40 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
Phase 3Not yet taking people in China
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Where
Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou, Jiaxing, Jinan, Liuzhou, Luoyang, Luzhou, Sanya, Shanghai, Shenyang, Shiyan, Suzhou, Wuhan, Xi'an, Xuancheng, Yuncheng, Zhengzhou
Age
18 years and over
People
330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07922330
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang, Hengshui, Huizhou, Lanzhou, Panjin, Qiqihar, Shanghai, Suzhou, Xiamen, Xianyang, Zigong
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
No phaseTaking people
Washed Microbiota Transplantation for Type 1 Diabetes Mellitus
Where
Nanjing
Age
3 years to 100 years
People
50
Run by
The Second Hospital of Nanjing Medical University
See details and how to joinNCT06256614
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Hohhot, Jinan, Lanzhou, Luoyang, Nanchang, Nanjing, Pingxiang, Shanghai, Shenyang, Shenzhen, Tianjin, Wuhan, Wuxi, Yueyang, Zhengzhou, Zhenjiang
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 2Not yet taking people in China
JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D
Where
Shanghai
Age
10 years to 40 years
People
132
Run by
Huijie Zhang
See details and how to joinNCT07845955
No phaseTaking people
Environmental Determinants of Type 1 Diabetes Risk
Where
Changsha
Age
3 years to 70 years
People
11,240
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07835724
No phaseTaking people
Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes
Where
Nanjing
Age
18 years to 70 years
People
80
Run by
Yang Tao
See details and how to joinNCT06273631
Phase 1Taking people
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Where
Kunming
Age
18 years to 50 years
People
36
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Beijing, Cangzhou, Changchun, Changde, Changzhou, Chengdu, Chongqing, Hefei, Huzhou, Jilin City, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Nanyang, Panjin, Shanghai, Shenzhen, Shijiazhuang, Shiyan, Suzhou, Xining, Zhengzhou, Zhenjiang
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
Early phase 1Enrolling by invitation
An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events
Where
Hefei
Age
18 years to 70 years
People
10
Run by
Celregen Therapeutics
See details and how to joinNCT07503028
No phaseTaking people
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
Where
Zibo
Age
18 years and over
People
36
Run by
SiBionics, Co, Ltd
See details and how to joinNCT07745244
No phaseTaking people
AI-Assisted Remote Insulin Pump Optimization in T1DM
Where
Nanjing
Age
14 years to 65 years
People
50
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07732777
Phase 2/3Taking people
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
Where
Nanjing
Age
18 years to 65 years
People
96
Run by
Nanjing Medical University
See details and how to joinNCT07548996
No phaseTaking people
Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study
Where
Changsha
Age
14 years to 50 years
People
2,950
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07621445
No phaseTaking people
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Where
Changsha, Changzhi, Haikou, Hangzhou, Harbin, Kunming, Lanzhou, Luoyang, Nanjing, Shenzhen, Ürümqi
People
20,000
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT05498974
Early phase 1Taking people
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
Where
Shanghai
Age
18 years to 40 years
People
9
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07528105
No phaseTaking people
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
Where
Shanghai
Age
Up to 18 years
People
50
Run by
Children's Hospital of Fudan University
See details and how to joinNCT03835312
No phaseTaking people
Intervention for Children With Type 1 Diabetes Targeting Gut Microbes
Where
Shanghai
Age
6 years to 12 years
People
110
Run by
Children's Hospital of Fudan University
See details and how to joinNCT06198725
No phaseTaking people
Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes
Where
Beijing
Age
4 years and over
People
340
Run by
Peking University First Hospital
See details and how to joinNCT07468474
Phase 3Taking people
Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
Where
Nanjing
Age
18 years to 65 years
People
90
Run by
Nanjing Medical University
See details and how to joinNCT07258394
Phase 1Taking people
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Where
Changsha, Chengdu, Shanghai
Age
18 years and over
People
45
Run by
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
See details and how to joinNCT04187443
Phase 1Taking people
Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus
Where
Tianjin
Age
18 years to 60 years
People
10
Run by
Hangzhou Reprogenix Bioscience, Inc
See details and how to joinNCT06731218
No phaseTaking people
Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients
Where
Beijing
Age
18 years and over
People
150
Run by
Peking University First Hospital
See details and how to joinNCT07144696
No phaseTaking people
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
Where
Beijing, Changsha, Chengdu, Hangzhou, Luoyang, Quanzhou, Shenyang, Shenzhen, Tangshan, Wuhan
Age
6 years and over
People
400
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07097818